Clinical Infectious Diseases · 2021 · 17 citations · 10 references
PharmacyInfectious DiseasesPharmacotherapyAntimicrobial PharmacologyAntimicrobial PharmacotherapyInfectious Disease PharmacotherapyAntibiotic ResistanceAntimicrobial DosingBacterial InfectionsDe-escalation Of Antimicrobial TherapyDefinitive Antimicrobial TherapyEmpiric Antimicrobial TherapyClostridioides Difficile Infection ControlClostridioides Difficile Infection TreatmentRecurrent Clostridioides Difficile Infection
We treated 46 patients with multiple recurrent Clostridioides difficile infections (mrCDI) using a tapered-pulsed (T-P) fidaxomicin regimen, the majority of whom failed prior T-P vancomycin treatment. Sustained clinical response rates at 30 and 90 days were 74% (34/46) and 61% (28/46). T-P fidaxomicin shows promise for management of mrCDI.
10
Fidaxomicin versus Vancomycin for <i>Clostridium difficile</i> Infection
Thomas Louie, Mark A. Miller, Kathleen M. Mullane et al. · New England Journal of Medicine · 2011 · 1.6K citations · Full text
Oliver A. Cornely, Derrick W. Crook, Roberto Esposito et al. · The Lancet Infectious Diseases · 2012 · 752 citations · Full text
Thomas Louie, Kristine Cannon, Brendan Byrne et al. · Clinical Infectious Diseases · 2012 · 305 citations · Full text
Benoît Guéry, Francesco Menichetti, Veli-Jukka Anttila et al. · The Lancet Infectious Diseases · 2017 · 219 citations · Full text